Search Within

Interventional Radiology Service

Formats
  1. Journal Article (746)
  2. Meeting Abstract (236)
  3. Review (73)
  4. Book Section (72)
  5. Editorial (32)
  6. Guidelines (18)
  7. Correspondence (9)
  8. Research Letter (6)
  9. Conference Paper (5)
  10. Book Whole (2)
  11. Miscellaneous (1)
Groups
  1. Radiology, Department of (1195)
  2. Center for Pancreatic Cancer Research (597)
  3. Sloan Kettering Institute Postdocs (313)
  4. Department of Medicine (309)
  5. Surgery (269)
  6. Solid Tumor Oncology Division (264)

More Groups

People
  1. Stephen Solomon (422)
  2. Constantinos Sofocleous (244)
  3. Joseph Erinjeri (200)
  4. Anne Covey (165)
  5. Karen Brown (142)
  6. Eric Lis (138)

More People

Years
  1. 2025 (38)
  2. 2024 (116)
  3. 2023 (94)
  4. 2022 (96)
  5. 2021 (62)
  6. 2020 (64)

More Years

Publications
  1. Journal of Vascular and Interventional Radiology (196)
  2. Journal of Clinical Oncology (74)
  3. CardioVascular and Interventional Radiology (55)
  4. American Journal of Roentgenology (40)
  5. Radiology (30)
  6. Journal of the National Comprehensive Cancer Network (28)

More Publications

Publishers
  1. Elsevier Science, Inc. (238)
  2. Springer (160)
  3. Elsevier Inc. (129)
  4. American Society of Clinical Oncology (81)
  5. American Roentgen Ray Society (40)
  6. Radiological Society of North America, Inc. (32)

More Publishers

Results (1200)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Outcomes by baseline tumour burden in EMERALD-1: A phase III, randomised, placebo (PBO)-controlled study of durvalumab (D) ± bevacizumab (B) with transarterial chemoembolisation (TACE) in participants (pts) with embolisation-eligible unresectable hepatocellular carcinoma (uHCC)
    Meeting Abstract

    Kudo, M.; Lencioni, R.; Erinjeri, J. P.; Chan, S. L.; Qin, S.; Ren, Z.; Arai, Y.; Heo, J.; Breder, V.; Bouattour, M.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Impact of baseline tumour burden on outcomes in EMERALD-1: A phase III study of durvalumab (D) ± bevacizumab (B) with transarterial chemoembolisation (TACE) in embolisation-eligible unresectable hepatocellular carcinoma (uHCC)
    Meeting Abstract

    Kudo, M.; Lencioni, R.; Erinjeri, J.; Chan, S. L.; Qin, S.; Ren, Z.; Arai, Y.; Heo, J.; Breder, V. V.; Bouattour, M.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • The RSNA Abdominal Traumatic Injury CT (RATIC) dataset
    Journal Article

    Rudie, J. D.; Lin, H. M.; Ball, R. L.; Jalal, S.; Prevedello, L. M.; Nicolaou, S.; Marinelli, B. S.; Flanders, A. E.; Magudia, K.; Shih, G. R.; more...
    Radiology: Artificial Intelligence (2024)

    Fulltext@MSK | Save
  • Development of an auto-segmentation method for mitigating sliding motion artifacts in time-resolved 4DMRI reconstruction
    Meeting Abstract

    Nie, X.; Gupta, V.; Zheng, S.; Dinh, A.; Friedman, A.; Liu, Y.; Li, G.
    Medical Physics (2024)

    Fulltext@MSK | Save
  • Variant arterial anatomy and choice of cannulation site in hepatic artery infusion pump placement: A 21-year retrospective review
    Meeting Abstract

    Schleimer, L. E.; Choubey, A.; Barekzai, A. B.; Geevarghese, R.; Marinelli, B.; Wei, A. C.; Jarnagin, W. R.; Kingham, T. P.; Soares, K. C.; D'Angelica, M. I.
    Journal of the American College of Surgeons (2024)

    Fulltext@MSK | Save
  • Liver venous deprivation to optimize liver hypertrophy: A single center experience
    Meeting Abstract

    Choubey, A.; Chou, J. F.; Gonen, M.; Wei, A. C.; Soares, K. C.; D'Angelica, M. I.; Jarnagin, W. R.; Santos, E.; Kingham, T. P.; Ridouani, F.
    Journal of the American College of Surgeons (2024)

    Fulltext@MSK | Save
  • safety analysis by treatment periods from Emerald-1: A phase 3, randomized, placebo-controlled study of transarterial chemoembolization with durvalumab with/without bevacizumab in participants with embolization-eligible unresectable hepatocellular carcinoma
    Meeting Abstract

    Chan, S.; Sangro, B.; Kudo, M.; Erinjeri, J.; Qin, S. K.; Ren, Z. G.; Arai, Y.; Breder, V.; Lin, S. M.; Peron, J. M.; more...
    Hepatology (2024)

    Fulltext@MSK | Save
  • Outcomes by baseline liver function in Emerald-1: A phase 3, randomized, placebo-controlled study of transarterial chemoembolization with durvalumab with/without bevacizumab in participants with embolization-eligible unresectable hepatocellular carcinoma
    Meeting Abstract

    Chan, S.; Decaens, T.; Kudo, M.; Erinjeri, J.; Lencioni, R.; Bouattour, M.; Breder, V.; Heo, J.; Mazzaferro, V.; Park, J. W.; more...
    Hepatology (2024)

    Fulltext@MSK | Save
  • Image-guided percutaneous robotic interventions for lung
    Review

    Geevarghese, R.; Bodard, S.; Jaleel, A.; Solomon, S. B.; Yarmohammadi, H.; Cornelis, F. H.
    Techniques in Vascular and Interventional Radiology (2024)

    Fulltext@MSK | Save
  • Integrating T-cell inflammation features for prognosis in hepatocellular carcinoma: A novel predictive model
    Journal Article

    Tang, P.; Wang, T.; Song, F.; Zhang, Y.; Zhao, Y.; Yarmohammadi, H.; Donadon, M.; Chen, Z.
    Journal of Gastrointestinal Oncology (2024)

    Fulltext@MSK | Save